THE EFFICACY OF ELRANATAMAB IN MAGNETISMM-3 COMPARED WITH A REAL-WORLD CONTROL ARM SIMULATING A COLOMBIAN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA POPULATION

EHA Library, Juan Manuel Reyes, 4162042

CLINICAL OUTCOMES OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA OVERALL AND AMONG LENALIDOMIDE-REFRACTORY PATIENTS IN EAST ASIA: A TARGETED LITERATURE REVIEW

EHA Library, Yi Tao, 4162043

D-VRD IN NEWLY DIAGNOSED MULTIPLE MYELOMA IN CHINA: A MULTICENTER REAL-WORLD STUDY COMPARING EFFICACY AND SAFETY WITH THE VRD REGIMEN

EHA Library, Yue Wu, 4162044

COMPARISON OF EFFICACY AND SAFETY BETWEEN IXAZOMIB BASED AND LENALIDOMIDE BASED INDUCTION IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Yan Wang, 4162045

CLINICAL CHARACTERISTICS OF 44 CHINESE PATIENTS WITH IGM-TYPE MULTIPLE MYELOMA: A MULTICENTER, RETROSPECTIVE, OBSERVATIONAL STUDY

EHA Library, Meilan Chen, 4162046

BCMA/GPRC5D BISPECIFIC CAR T-CELL THERAPY FOLLOWING APATINIB BRIDGING TREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE: A SINGLE-ARM, SINGLE-CENTER PHASE 1 TRIAL

EHA Library, Ling Qiu, 4162047

A JOURNEY THROUGH UNDERSTANDING AND MANAGING WALDENSTROMS MACROGLOBULINEMIA (WM): 13 YEARS OF INSIGHT

EHA Library, Dibakar Podder, 4162048

DETERMINATION OF THE BIOLOGICAL VARIATION OF SOLUBLE B-CELL MATURATION ANTIGEN

EHA Library, Oscar Berlanga, 4162049

SUPPORTING TREATMENT DECISION-MAKING FOR LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA PATIENTS POST-DRD IN ITALY: A MULTI-CRITERIA DECISION FRAMEWORK

EHA Library, Mario Boccadoro, 4162050

REAL-LIFE EXPERIENCE WITH FIRST-LINE TREATMENT WITH DARATUMUMAB-BASED THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA INELIGIBLE FOR AUTOLOGOUS STEM-CELL TRANSPLANTATION.

EHA Library, Francesca Fazio, 4162051

TRIAL IN PROGRESS: PHASE 1B, DOSE ESCALATION/DOSE EXPANSION STUDY OF OPN-6602 MONOTHERAPY AND IN COMBINATION WITH DEXAMETHASONE IN SUBJECTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Andrew Sochacki, 4162052

PRE-DIAGNOSTIC ROUTINE LABORATORY TESTING PATTERNS IN PEOPLE WITH MULTIPLE MYELOMA REFERRED TO A TERTIARY SOUTH AFRICAN HOSPITAL

EHA Library, Ryan Aylward, 4162053

A NON-INTERVENTIONAL, PROSPECTIVE, POST-AUTHORIZATION SAFETY STUDY IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL: TRIAL IN PROGRESS

EHA Library, Ralph Wäsch, 4162054

DOES INCORPORATING ANTI-CD38 ANTIBODIES TO THE FIRST LINE TREATMENT FOR MULTIPLE MYELOMA HAVE ANY IMPACT ON EARLY MORTALITY? EXPERIENCE OF A SINGLE CENTER.

EHA Library, Sunil Lakhwani, 4162055

SUCCESSFUL EARLY RESCUE WITH ISATUXIMAB PLUS CARFILZOMIB-DEXAMETHASONE (ISA-KD) IN DARATUMUMAB-REFRACTORY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH „NO WASHOUT PERIOD”.

EHA Library, Paula Gili Herreros, 4162056

FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1 TRIAL DESIGN OF SAR446523, A NOVEL ANTI-GPRC5D ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC)-ENHANCED MONOCLONAL ANTIBODY FOR MULTIPLE MYELOMA

EHA Library, Prashant Kapoor, 4162057

TRANSGELIN-2 AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL DAMAGE.

EHA Library, Rasha Mohamed Said, 4162058

CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS WITH MULTIPLE MYELOMA: A REAL-WORLD RETROSPECTIVE STUDY IN JAPAN USING ELECTRONIC HEALTH RECORDS

EHA Library, Nami Tagami, 4162059

TRIAL IN PROGRESS: QUINTESSENTIAL-2—A PHASE 3 STUDY OF ARLOCABTAGENE AUTOLEUCEL VERSUS STANDARD OF CARE IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO LENALIDOMIDE

EHA Library, Rakesh Popat, 4162060

OVERCOMING PRIMARY RESISTANCE TO ANTI-BCMA BISPECIFIC ANTIBODY THERAPY THROUGH MULTIMODAL SBCMA DEBULKING IN A PATIENT WITH TRIPLE EXPOSURE TO TECLISTAMAB

EHA Library, Sven Neubert, 4162062

CARFILZOMIB, POMALIDOMIDE, DEXAMETHASONE WITH AND WITHOUT DARATUMUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MULTI-CENTER, PROSPECTIVE REAL WORLD STUDY IN CHINA

EHA Library, Fujing Zhang, 4162063

P-SELECTIN AND SST2 IN PROGNOSIS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH MULTIPLE MYELOMA AFTER ANTINEOPLASTIC TREATMENT AND SEVERE COVID-19

EHA Library, Borys Samura, 4162064

TRENDS IN CLINICAL CHARACTERISTICS, TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): A SINGLE CENTER REAL WORLD DATA OF OVER 12 YEARS

EHA Library, Mamta Garg, 4162065

LONG-TERM SURVIVAL IN MULTIPLE MULTIPLE MYELOMA PATIENTS: A SINGLE-CENTRE STUDY

EHA Library, Pedro Pinho Moura, 4162067

IMPLEMENTING A COMPETITIVE FUNDING SCHEME FOR ADVANCING THE QUALITY OF CARE FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING TREATMENT WITH BISPECIFIC ANTIBODIES.

EHA Library, Joseph Mikhael, 4162068

REAL-WORLD EVALUATION OF DARATUMUMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (D-VRD) INDUCTION FOLLOWED BY DARATUMUMAB AND LENALIDOMIDE (DR) MAINTENANCE IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA

EHA Library, Joao Tadeu Souto Filho, 4162069

A PHASE I/IIA STUDY TO EVALUATE INOBRODIB IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES: DOSE EXPANSION COHORTS OF INOBRODIB IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Emma Searle, 4162070

EFFICACY AND SAFETY OF SELINEXOR, CARFILZOMIB, POMALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE: A PROSPECTIVE MULTI-CENTER SINGLE-ARM STUDY

EHA Library, Hai Zhou, 4162071

TRIAL IN PROGRESS: PHASE I/II STUDY OF MEZIGDOMIDE AND ELRANATAMAB FOR RELAPSED/ REFRACTORY MULTIPLE MYELOMA PATIENTS (MELT-MM)

EHA Library, Ja Min Byun, 4162072

UNVEILING OSTEOPOROSIS IN PATIENTS DIAGNOSED WITH MGUS.IS THERE A NEED OF INTERVENTION?THE EXPERIENCE OF OUR DEPARTMEN AND VA BRIEF REVIEW.

EHA Library, THEOFANIA PETRA, 4162073

A REAL-WORLD STUDY ON THE EFFICACY AND SAFETY OF POMALIDOMIDE AS MAINTENANCE THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Ling Qin, 4162074

MISSED OPPORTUNITIES IN AL AMYLOIDOSIS: HOW E' VELOCITY, PERICARDIAL EFFUSION BIOMARKERS, AND DELAYED AMYLOID TYPING IMPACT ASTCT ELIGIBILITY

EHA Library, Sabina Loredana Georgiana Olteanu, 4162075

CYTOGENETIC ANALYSIS OF MULTIPLE MYELOMA PATIENTS: SINGLE CENTER REPORT

EHA Library, Iva Semren, 4162076

SOCIAL DETERMINANTS OF HEALTH, TRANSITION OF CARE, AND OUTCOMES AMONG REAL-WORLD RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS TREATED WITH TECLISTAMAB

EHA Library, Amir Ali, 4162077

REAL-WORLD EXPERIENCE OF CYTOKINE RELEASE SYNDROME AND INFECTION INCIDENCE POST-ELRANATAMAB THERAPY IN AN NHS TERTIARY CENTRE: A CASE SERIES

EHA Library, Kinda Al-Hourani, 4162078

TREATMENT OF PLASMA CELL DISORDERS POST SOLID ORGAN TRANSPLANT - A POSITIVE SINGLE CENTER EXPERIENCE USING IMMUNOMODULATORY DRUGS

EHA Library, Khalida Soki, 4162079

UNRAVELLING THE CHARACTERISTICS AND OUTCOMES OF MULTIPLE MYELOMA WITH CHROMOSOME 1Q GAIN

EHA Library, Meher lakshmi Konatam, 4162080

CIRCULATING TUMOR CELLS IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS - THE NEW BIOMARKER OF DISEASE BURDEN

EHA Library, Marko Mitrovic, 4162081

INVESTIGATION OF C-MAF PROTEIN EXPRESSION IN PATIENTS WITH MULTIPLE MYELOMA WITH T(14;16)

EHA Library, Maiia Soloveva, 4162082

PROTEASOME INHIBITORS RELATED THROMBOTIC MICROANGIOPATHY

EHA Library, CAN CHEN, 4162083

BRIDGING GAPS IN AL AMYLOIDOSIS: ASSESSING THE EFFECTIVENESS OF MULTIDISCIPLINARY ONLINE CME/CE EDUCATION

EHA Library, Sarah Elizabeth Bomba, 4162084

REFRACTORY MULTIPLE MYELOMA IN YOUNG PATIENTS: PROGNOSTIC FACTORS AND THERAPEUTIC IMPACT

EHA Library, Faten kallel, 4162085

THE OUTCOMES OF DARATUMUMAB-CONTAINING REGIMENS IN PATIENTS WITH MULTIPLE MYELOMA ACROSS DIFFERENT LINES OF THERAPIES: SINGLE-CENTER REAL-WORLD EXPERIENCES

EHA Library, Yan Wang, 4162086

RAPID AND UNEXPECTED THERAPEUTIC RESPONSE TO LOW-DOSE INTRAVENOUS MELPHALAN IN PATIENTS WITH PENTA-REFRACTORY MULTIPLE MYELOMA PROGRESSING AFTER TREATMENT WITH ANTI-GPRC5D T-CELL REDIRECTING BISPECIFIC ANTIBODIES

EHA Library, Francesco Volzone, 4162087

REAL-WORLD INFUSION OF INTRAVENOUS ISATUXIMAB IN 30-MINUTE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA. EXPERIENCE OF 5 CENTERS IN SPAIN.

EHA Library, Xabier Gutierrez Lopez De Ocariz, 4162088

THE INCIDENCE OF SECOND PRIMARY MALIGNANCY IN MYELOMA PATIENTS: REAL-WORLD DATA FROM A SECONDARY HEALTHCARE SERVICE.

EHA Library, Ahmed Sadek, 4162089

SELINEXOR IN COMBINATION WITH MELPHALAN CONDITIONING REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

EHA Library, Jiali Li, 4162091

AUDIT OF ZOMETA PRESCRIBING IN PATIENTS WITH MULTIPLE MYELOMA AT GUY'S AND ST THOMAS' NHS FOUNDATION TRUST

EHA Library, Priya Khoda, 4162092

POST-AUTOGRAFT RELAPSE IN MULTIPLE MYELOMA: CLINICAL AND BIOLOGICAL PROFILES

EHA Library, safia chebrek, 4162093

SELINEXOR COMBINED WITH BENDAMUSTINE, BORTEZOMIB, AND DEXAMETHASONE (X-BENBD) REGIMEN FOR THE TREATMENT OF MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE

EHA Library, Li Gao, 4162094

DARATUMUMAB-BASED TREATMENTS IN STAGE IIIB AL AMYLOIDOSIS: REAL LIFE EXPERIENCE FROM ANCONA TERTIARY CENTER

EHA Library, Massimo Offidani, 4162095

IMPACT OF HEMCR AFTER ONE CYCLE OF TREATMENT IN AL AMYLOIDOSIS PATIENTS – SINGLE CENTER EXPERIENCE FROM UMC LJUBLJANA, SLOVENIA

EHA Library, Gaja Cvejić Vidali, 4162096

UNIVERSAL USE OF NOVEL ORAL ANTICOAGULANTS IN NEWLY DIAGNOSED OR RELAPSED REFRACTORY MYELOMA PATIENTS RECEIVING IMMUNOMODULATORY DRUGS AS PART OF THEIR THERAPY

EHA Library, Yaşa Gül Mutlu, 4162097

CHALLENGES IN TREATING MULTIPLE MYELOMA IN RESOURCE-POOR SETTINGS: A REAL-WORLD EXPERIENCE

EHA Library, Karan Sood, 4162098

CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS FOR PRIMARY MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE: A MULTICENTER CHINESE RETROSPECTIVE COHORT STUDY

EHA Library, Yang Liu, 4162099

THE JOURNEY OF A PATIENT WITH IGM DETECTION IN A TERTIARY CENTER - REVIEW OF 3 YEARS EXPERIENCE

EHA Library, Inês Gonçalves, 4162100

EARLY DIAGNOSIS OF AL-AMYLOIDOSIS

EHA Library, Veronika Pinchuk, 4162101

ENHANCING PROGNOSTIC PRECISION OF NEWLY DIAGNOSED MULTIPLE MYELOMA IN REAL-WORLD: THE DPA-RISS MODEL ADJUSTED FOR PLATELET DYNAMICS

EHA Library, Menghao Wei, 4162102

THE EFFICACY AND SAFETY OF SELINEXOR AS MAINTENANCE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA(RRMM) WITH EXTRAMEDULLARY DISEASE (EMD) AFTER CAR-T CELL THERAPY

EHA Library, Zhenyu Li, 4162103

CLINICAL CHARACTERISTICS AND PROGNOSIS ANALYSIS OF 13 CASES OF NEWLY DIAGNOSED PLASMABLASTIC LYMPHOMA

EHA Library, bingling guo, 4162104

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF MGRS (MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE): EXPERIENCE FROM A REFERRAL CENTER

EHA Library, Daniel Cabello Modesto, 4162105

BORTEZOMIB IN MULTIPLE MYELOMA: A THERAPEUTIC BREAKTHROUGH IN TUNISIA

EHA Library, Wafa Sakli, 4162106

COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MULTIPLE MYELOMA-RELATED SECONDARY HYPOGAMMAGLOBULINEMIA

EHA Library, Federico Spataro, 4162107

TREATMENT OUTCOMES AND STEM CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS RECEIVING VCD INDUCTION FOLLOWED BY LENALIDOMIDE MAINTENANCE: A RETROSPECTIVE COHORT STUDY.

EHA Library, Liu Hongchen, 4162108

CARFILZOMIB-BASED CHEMOTHERAPY REGIMEN FOR THE TREATMENT OF MULTIPLE MYELOMA:A REAL-WORLD STUDY IN CHINESE POPULATION

EHA Library, Li Hui, 4162109

VCD VERSUS VTD IN NEWLY DIAGNOSED MULTIPLE MYELOMA - ANALYSIS OF A BRAZILIAN PUBLIC INSTITUTION

EHA Library, Pedro Henrique Fernandes do Carmo Las Casas, 4162110

A RETROSPECTIVE AUDIT OF PRIMARY PLASMA CELL LEUKEMIA FROM A SINGLE TERTIARY CARE CENTER IN EASTERN INDIA.

EHA Library, Debranjani Chattopadhyay, 4162111

COMPLIANCE WITH NATIONAL GUIDELINES (NICE/BCSH) ON BISPHOSPHONATE THERAPY IN MULTIPLE MYELOMA - A RETROSPECTIVE AUDIT

EHA Library, Sumitha Niyomi Nanayakkara, 4162112

PLASMACYTOMA: DIAGNOSTIC ASPECTS AND THERAPEUTIC OUTCOMES

EHA Library, Aya Zaouali Dridi, 4162113

SOLITARY PLASMACYTOMA - A REAL WORLD OUTCOME ANALYSIS FROM INDIA

EHA Library, Dibakar Podder, 4162114

INITIATION OF DARATUMUMAB IN A LOW-RESOURCE REGION: CHALLENGES AND OUTCOMES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Faten kallel, 4162115

A RETROSPECTIVE ANALYSIS OF AL-AMYLOIDOSIS IN A TERTIARY CARE CANCER CENTER IN INDIA

EHA Library, Dibakar Podder, 4162116

A SUCCESSFUL USE OF A COMBINATION OF DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE IN THE FIRST-LINE THERAPY OF POEMS SYNDROME

EHA Library, Svetlana Akulshina, 4162117

EFFICACY AND SAFETY OF CARFILZOMIB-BASED REGIMENS IN MULTIPLE MYELOMA: A RETROSPECTIVE STUDY

EHA Library, Jun Huang, 4162118

DARATUMUMAB-LENALIDOMIDE-DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA NOT CANDIDATES FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION: EXPERIENCE AT OUR CENTER

EHA Library, Laura García Tejero, 4162119

IMPACT OF IVIG ON INFECTION RATES AND HOSPITALISATION IN PATIENTS RECEIVING BISPECIFIC ANTIBODIES FOR RELAPSED REFRACTORY MULTIPLE MYELOMA

EHA Library, Yung Nga Tse, 4162120

CLINICAL CHARACTERIZATION OF LISTERIA MONOCYTOGENES INFECTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Tao Wu, 4162121

DIAGNOSTIC BIOMARKERS FOR PRIMARY MYELOFIBROSIS: A MACHINE LEARNING MODEL BASED ON INFLAMMATION-RELATED GENES AND CLINICAL DATA VALIDATION

EHA Library, Jian Huang, 4162122

MUTATIONAL SPECTRUM IN SECONDARY MYELOFIBROSIS: BIOLOGICAL WAYS OF SURVIVAL IN MYELOID NEOPLASTIC CLONES

EHA Library, Eduardo Rodríguez-Arbolí, 4162123

DYSREGULATION OF PLATELET IMMUNOPHENOTYPE AND GENE SIGNATURE FUELS THROMBOINFLAMMATION IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Vitor Bassan, 4162124

ELEVATED PLATELET CREB3L1 EXPRESSION IMPLICATES UNIQUE DISEASE PHENOTYPES IN MPN PATIENTS AND EFFECTIVELY DIFFERENTIATES BETWEEN MPN AND NON-CLONAL CYTOSIS

EHA Library, Chih-Cheng Chen*, 4162125

SINGLE-CELL TRANSCRIPTOMICS OF JUVENILE MYELOMONOCYTIC LEUKEMIA AND RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER

EHA Library, Alexandr Ikonnikov, 4162126

MUTATIONAL PROFILE BEYOND CKITD816V IN SYSTEMIC MASTOCYTOSIS: THE ROLE OF KITM541L IN DISEASE PATHOGENESIS AND CLINICAL MANIFESTATIONS. DATA FROM A SINGLE CENTER EXPERINCE

EHA Library, Manlio Fazio, 4162127

SINGLE CELL TRANSCRIPTOMIC ANALYSIS AND CLINICAL PROFILE OF TWO MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH NEUTROPHILIA PATIENTS TREATED WITH AZACYTIDINE

EHA Library, Silvia Spinelli, 4162128

THE EFFECT OF THE MUTATION PROFILE AND CHROMOSOMAL ABERRATIONS ON THE EFFECTIVENESS OF RUXOLITINIB FOR PATIENTS WITH PRIMARY MYELOFIBROSIS

EHA Library, Anna Kirienko, 4162129

UNMET NEEDS & TREATMENT GAPS AMONG PATIENTS WITH POLYCYTHEMIA VERA: A RETROSPECTIVE MEDICAL CHART AUDIT STUDY

EHA Library, Andrew Howe, 4162130

MARKERS OF INFLAMMATION, DISEASE PROGRESSION AND THEIR ASSOCIATION WITH NGS AND CHIP MUTATIONS IN MYELOPROLIFERATIVE NEOPLASMS: IMPLICATIONS FOR THERAPEUTIC DECISION-MAKING

EHA Library, Laura Gabriela Tirlea, 4162132

COEXISTENCE OF LOW BURDEN ALLELE JAK2 V617F MUTATION AND CALR OR MPL MUTATIONS IN A LARGE COHORT OF PATIENTS WITH CHRONIC MYELOPROLIFERATIVE SYNDROMES.

EHA Library, Cosimo Barbato, 4162133

IMMUNE-MEDIATED PLATELET ACTIVATION VIA FCGR2A: PROTHROMBOTIC MECHANISMS IN JAK2V617F+ POLYCYTHEMIA VERA

EHA Library, Mathias Björlin, 4162134

DNA METHYLTRANSFERASE INHIBITOR DECITABINE ENHANCES THE CYTOTOXIC EFFECT OF RUXOLITINIB IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Jian Huang, 4162135

ANTIOXIDANT ENZYMES AND MITOCHONDRIAL FUNCTION IN JAK2 V617F-POSITIVE MPN

EHA Library, Ivona Aric Zrna, 4162136

EPIDEMIOLOGICAL DATA OF RARE MYELOID MALIGNANCIES FROM A 42-Y-OLD POPULATION-BASED SPECIALISED REGISTRY IN FRANCE.

EHA Library, Marc Maynadié, 4162137

COMPREHENSIVE NEXT-GENERATION SEQUENCING APPROACH IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Alejandro Zurdo, 4162138

ANALYSIS OF THE MECHANISM OF THE FIBROCYTE-MEDIATED INDUCTION OF MYELOFIBROSIS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Takaaki Maekawa, 4162139

SHORT AND HYPOMETHYLATED JAK2V617F+SSDNA MODULATES DIS3 RIBONUCLEASE ACTIVITY

EHA Library, Esra Nur Demirtaş, 4162140

EFFECT OF THERAPEUTICALLY TARGETING BET BROMODOMAINS IN ENHANCING MARKERS OF MACROPHAGE PHAGOCYTOSIS AS A NOVEL IMMUNOTHERAPEUTIC STRATEGY FOR MPN

EHA Library, Ciro Rinaldi, 4162141

A RARE MYELOPROLIFERATIVE DISEASE: CHRONIC EOSINOPHILIC LEUKEMIA, NEW GENETIC FEATURES?

EHA Library, Michela Schirru, 4162143

A DELPHI CONSENSUS TO DEFINE DISEASE PROGRESSION AND DISEASE MODIFICATION IN POLYCYTHEMIA VERA

EHA Library, Prithviraj Bose, 4162145

CLINICAL AND MOLECULAR CHARACTERISTICS OF MYELOPROLIFERATIVE NEOPLASMS PATIENTS WITH NFE2 GENE MUTATION

EHA Library, Songyang Zhao, 4162146

CLINICAL STUDY ON THE EARLY EFFICACY AND SAFETY OF LUSPATERCEPT IN TREATING ANEMIA IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Junyao Huang, 4162147